Authors included Rozalina G
Considering the timing of GLP-1RAs initiation after bariatric surgery, recent studies indicate that the proper healing and metabolic adaptations that occur following bariatric procedures, such as changes in gut hormones and insulin sensitivity, may play a role in the effectiveness of GLP-1RAs [73]
Frontiers in Endocrinology, 14, 1184302
Dinour D, Gray NK, Campbell S, et al
We confirm that co-treatment with 5FU and mitochondrial inhibitors, particularly CI inhibitors IACS-010759 (a specific CI inhibitor under clinical evaluation 51 ) and metformin hydrochloride (a treatment for diabetes that inhibits CI 52 ), increases growth arrest and death in CRC cells (Fig
These potential fixed-dose combination therapies, comprising amylin and GLP-1/glucagon receptor agonists, target enhanced weight loss and organ protection